Hi-Tech Pharmacal Income Statement
View: Annual | Quarterly
| Apr 09 | Apr 08 | Apr 07 | |
|---|---|---|---|
| Revenue | 108.7 | 62.0 | 58.9 |
| Cost of Goods Sold | 57.0 | 40.5 | 35.7 |
| Gross Profit | 51.7 | 21.5 | 23.2 |
| Gross Profit Margin | 47.6% | 34.7% | 39.4% |
| SG&A Expense | 33.3 | 22.6 | 23.9 |
| Depreciation & Amortization | 3.6 | 2.9 | 2.8 |
| Operating Income | 15.9 | (6.8) | (4.0) |
| Operating Margin | 14.6% | -- | -- |
| Nonoperating Income | -- | 0.0 | 0.0 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | 15.8 | (6.9) | (4.0) |
| Income Taxes | 6.0 | (1.8) | (2.0) |
| Net Income After Taxes | 9.8 | (5.1) | (2.0) |
| Continuing Operations | 9.8 | (5.1) | (2.0) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 9.8 | (5.1) | (2.0) |
| Total Net Income | 9.8 | (5.1) | (2.0) |
| Net Profit Margin | 9.0% | -- | -- |
| Diluted EPS from Total Net Income ($) | 0.84 | (0.45) | (0.17) |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
